Navigation Links
Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
Date:11/12/2012

WASHINGTON, Nov. 12, 2012 /PRNewswire/ -- New Phase 3 findings from a Janssen Research & Development, LLC (Janssen)-sponsored study showed treatment with the investigational intravenous (I.V.) therapy golimumab, a tumor necrosis factor (TNF) inhibitor, significantly inhibited radiographic progression in patients with active moderate to severe rheumatoid arthritis (RA) despite treatment with methotrexate.  Analysis of study patients' X-rays showed significant inhibition of the progression of structural damage at week 24 in greater proportions of patients receiving I.V. golimumab plus methotrexate compared with patients receiving placebo plus methotrexate.  The inhibition of structural damage progression was maintained in patients randomized to I.V. golimumab through week 52, and inhibition of structural damage progression was observed at week 52 in patients receiving placebo who crossed over to I.V. golimumab at week 24.  Treatment with I.V. golimumab plus methotrexate also led to improvements in signs and symptoms and disease activity with nearly 60 percent of patients achieving at least a 20 percent improvement in the American College of Rheumatology (ACR 20) score at week 14, the study's primary endpoint, and nearly two-thirds of patients achieving that response at week 52.  These data are being presented at the 2012 Annual Meeting of the American College of Rheumatology.     

In September, Janssen announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) requesting approval of I.V. golimumab in combination with methotrexate for the treatment of adults with moderately to severely active RA.  Golimumab is currently marketed as SIMPONI® (golimumab), a subcutaneous injection approved by the United States Food and Drug Administration (FDA) for the treatment of moderately to severely active RA with the medicine methotrexate, active
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... New Jersey , 22. Mai 2013 ... für Fähigkeitsentwicklung und Beratung, gab heute bekannt, ... Chris Geraghty , zum Hauptgeschäftsführer ... 20 Jahre im Industriebereich wo er zahlreiche ... Nachfolge von Ray Baxter an, der als ...
(Date:5/22/2013)... Z-Medica, a leading developer and marketer of ... line of products designed to meet the unique needs ... EMS 4x4 Dressing, QuikClot ® EMS TraumaPad ... all custom-designed to help responders stop bleeding fast and ... a hospital or trauma center. The line includes products ...
(Date:5/22/2013)... May 22, 2013  MGT Capital Investments, Inc. (NYSE ... at the Second Annual Marcum LLP MicroCap Conference on ... City at the Grand Hyatt Hotel.  ... Officer, will update investors and answer questions. ... presentation is scheduled to begin at 9:30 a.m. EDT.  ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4
(Date:5/22/2013)... Digital Advertising Agency, 21Digital , has ... media management client, Primal Pit Paste . One ... all-natural organic deodorant. The contest is part of a ... deodorant company based in Tampa, Florida. 21Digital president, Kevin ... a Facebook page is a great way to drive ...
(Date:5/22/2013)... 2013 With the health of a growing ... is no surprise that many women become hyperaware of everything ... two lines appear on a pregnancy test. At no other ... avoid unhealthy habits (like caffeine, alcohol, and nicotine) stronger than ... on their bodies? Does this increased awareness during pregnancy extend ...
(Date:5/22/2013)... 2013 Garcinia cambogia select is a dual ... inhibiting the extra fat being stored in the body. For ... intake. This fat burner helps people in this regard by ... overeating. Basically it does this by secreting a hormone serotonin ... them away from emotional overeating. In this way, it keeps ...
(Date:5/22/2013)... May 22, 2013 GS1 has honored ... Smucker Company, and Danny Wegman, CEO, Wegmans Food ... GS1 General Assembly and Global Leadership Summit, held May ... Wegman were recognized for their outstanding contributions to the ... broadly used supply chain standards globally. , “The ...
(Date:5/22/2013)... -- Children and teens exposed to radiation during CT ... according to a large, long-term study. The risks, ... young people who each had one CT scan, only ... within 10 years, according to researchers from Australia and ... the risks to patients when making decisions about CT ...
Breaking Medicine News(10 mins):Health News:Social Media Management Firm, 21Digital, Launches National Facebook Sweepstakes for Client, Primal Pit Paste 2Health News:Fairhaven Health Launches New PregnancyPlus Natural Deodorant Designed Specifically for Pregnant Women 2Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2
... ENT and ... joined the Practice — otolaryngologist Tamekia Wakefield, M.D. , ... Tarrytown, NY (Vocus) May 17, 2010 -- ENT ... physician has joined the Practice — otolaryngologist Tamekia Wakefield, M.D. She will join ENTA on ...
... A study published last week in Archives of Internal ... significantly lowered total and LDL-cholesterol levels, in addition to triglycerides. ... seven counties, is the most comprehensive study of its kind ... the risk of cardiovascular disease. The report, authored by ...
... ... look for. Flexible Assembly Systems uncovers the great torque screwdriver mystery with its very own ... ... don’t know what to look for. A torque screwdriver comes in many different variations, ...
... ... Business Process Consulting practice to guide emerging companies in their migration from manual, spreadsheet-based HR ... ... businesses stood to gain so much, by transitioning to automated HR platforms. A number ...
... ... on Thursday May 27, 2010 at the MacLaren Art Centre in Barrie, Ontario. The session ... , ... 17, 2010 -- Barrie area physicians are invited to attend the session which will start ...
... Software now ... ... Works, the developer of Statistical Process Control (SPC) and data collection software, announces the release ... process automation. The software offers many new enhancements for statistical process control, and ease of ...
Cached Medicine News:Health News:ENT and Allergy Associates Welcomes Tamekia L. Wakefield, MD, Further Reinforcing its Pediatric Sinus Expertise and Capabilities in Queens , , 2Health News:ENT and Allergy Associates Welcomes Tamekia L. Wakefield, MD, Further Reinforcing its Pediatric Sinus Expertise and Capabilities in Queens , , 3Health News:Pistachios: A handful a day may keep the cardiologist away 2Health News:Flexible Assembly Systems Announces Torque Screwdriver Application Guide 2Health News:Economic Recovery and New Healthcare Legislation: The Stars Are Aligned for Increased Adoption of HR Management Systems (HRMS) 2Health News:Economic Recovery and New Healthcare Legislation: The Stars Are Aligned for Increased Adoption of HR Management Systems (HRMS) 3Health News:SPC Works Releases SPC Software for Process Automation 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: